Victory Capital Management »

Halozyme Therapeutics shares owned by Victory Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Victory Capital Management from 13F filings

Historical chart of Victory Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Victory Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Victory Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.2M 9.5M 0.86
2023-09-30 $11M 13M 0.84
2023-06-30 $11M 14M 0.83
2023-03-31 $6.7M 7.9M 0.85

More positions owned by Victory Capital Management

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Victory Portfolios Ii Etf (UITB)
Facebook Inc cl a (META)
Alphabet Inc Class C cs (GOOG)
Broadcom (AVGO)
Tesla Motors (TSLA)
Ross Stores (ROST)
Alphabet Inc Class A cs (GOOGL)
Leidos Holdings (LDOS)
JPMorgan Chase & Co. (JPM)
Textron (TXT)
Xcel Energy (XEL)

View all positions for Victory Capital Management

Top funds holding Halozyme Therapeutics

Wellesley Investment Advisors
Davidson Kempner Capital Management
Lazard Asset Management
Citigroup
Aviva
Citadel Advisors
D. E. Shaw & Co
Wells Fargo & Company
Readystate Asset Management
Tenor Capital Management
Wolverine Asset Management
Victory Capital Management
Jpmorgan Chase & Co
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Shenkman Capital Management

View all funds holding Halozyme Therapeutics